12:00 AM
Jan 07, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Xiaflex: Phase Ib data

Top-line data from an open-label, dose-escalation, U.S. Phase Ib trial in 99 women aged 21-60 years showed that collagenase clostridium histolyticum injected over a pre-defined 8 x 10 cm template around a target dimple led to "some improvement" in the volume of the target cellulite dimple in 63% of patients at day 30. Additionally, 17% of patients had a >=30% improvement in their target dimple volume at day 30. The most common treatment-related adverse events...

Read the full 353 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >